Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference

Rhea-AI Summary

Wave Life Sciences, a clinical-stage biotech company, will present at the 2024 Jefferies Global Healthcare Conference. The event is scheduled for June 6, 2024, at 7:30 a.m. ET, and will feature a presentation by Paul Bolno, the CEO. A live webcast will be accessible through the Investor Relations page on the company's website, with a replay available for a time. This event provides insight into the company's progress in RNA medicines aimed at transforming human health.

Positive

• CEO Paul Bolno will present at a high-profile event, potentially attracting investor interest.
• A live webcast and replay availability enhance transparency and accessibility for investors.
• Focus on RNA medicines, which are considered cutting-edge in biotech.

Negative

• No new financial or clinical data were disclosed in the announcement, limiting substantive investor insights.
• Upcoming event details do not ensure immediate stock performance improvements.

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 2024 Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024, at 7:30 a.m. ET.

A live webcast of this presentation will be available on the Investor Relations page of the Wave Life Sciences website at http://ir.wavelifesciences.com. A replay of this presentation will be archived and available on the site for a limited time following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM™, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. Driven by the calling to “Reimagine Possible”, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) and LinkedIn.

Investor Contact:
Kate Rausch
+1 617-949-4827
krausch@wavelifesci.com

Media Contact:
Alicia Suter
+1 617-949-4817
asuter@wavelifesci.com

FAQ

When will Wave Life Sciences present at the Jefferies Global Healthcare Conference?

Wave Life Sciences will present on June 6, 2024, at 7:30 a.m. ET.

How can I watch the Wave Life Sciences 2024 Jefferies presentation?

You can watch the live webcast on the Investor Relations page of the Wave Life Sciences website.

Will there be a replay of the Wave Life Sciences presentation at the 2024 Jefferies Conference?

Yes, a replay will be available on the company's website for a time after the event.

What is the focus of Wave Life Sciences' work?

Wave Life Sciences focuses on developing RNA medicines to transform human health.

Who is presenting for Wave Life Sciences at the 2024 Jefferies Global Healthcare Conference?

Paul Bolno, the President and CEO of Wave Life Sciences, will be presenting.